Barclays Maintains Equal-Weight on Zimmer Biomet Holdings, Raises Price Target to $115

Benzinga · 1d ago
Barclays analyst Christopher Pasquale maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight and raises the price target from $100 to $115.